KCNH2 and cancer: These data indicate that Kv11.1 activity can control a potent anticancer mechanism that suppresses stemness behavior and the mesenchymal phenotype of cancer cells while promoting the stationary feature of the epithelial phenotype; a reversing process from EMT into MET.